Measurement of Multiple Drug Resistance Transporter Activity in Putative Cancer Stem/Progenitor Cells
Multiple drug resistance, mediated by the expression and activity of ABC-transporters, is a major obstacle to antineoplastic therapy. Normal tissue stem cells and their malignant counterparts share MDR transporter activity as a major mechanism of self-protection. Although MDR activity is upregulated in response to substrate chemotherapeutic agents, it is also constitutively expressed on both normal tissue stem cells and a subset of tumor cells prior to the initiation of therapy, representing a built-in obstacle to therapeutic ratio. Constitutive and induced MDR activity can be detected in cellular subsets of disaggregated tissues, using the fluorescent substrates Rhodamine 123 and Hoechst 33342 for ABCB1 (also known as P-gp and MDR1) and ABCG2 (BCRP1). In this chapter, we will describe the complete procedure for the detection of MDR activity, including: (1) Preparing single-cell suspensions from tumor and normal tissue specimens; (2) An efficient method to perform cell surface marker staining on large numbers of cells; (3) Flow cytometer setup and controls; (4) Simultaneous measurement of Hoechst 33342 and Rhodamine123 transport; and (5) Data acquisition and analysis.
- Adenovirus-Mediated Drug-Sensitivity Gene Therapy for Hepatocellular Carcinoma
- Cclooxygenase-2 (COX-2) Protein Expression by Western Blotting
- Serial Analysis of Gene Expression (SAGE)
- Immunocytochemical Detection and Characterization of Individual Micrometastatic Tumor Cells
- Detection of t(2;5)(p23;q35)Translocation by Long-Range PCR of Genomic DNA
- Electroporative Gene Transfer
- Molecular Cytogenetic Applications in Analysis of the Cancer Genome
- 用于组织工程研究的水凝胶三维包裹细胞法
- 光调控细胞功能——新的研究方向
- Clonality Detection of Expanded T-Cell Populations in Patients With Multiple Myeloma